Catalpol Workflows for Neuroprotection Research
2026-08-20
Catalpol, also indexed as Catalpinoside, supports mechanism-led studies that connect oxidative stress, inflammation, and neuronal survival. This practical guide covers assay selection, dose planning, model translation, and troubleshooting across neuroprotection research, ischemic injury, bone loss, and fibrosis workflows.
(-)-Blebbistatin: Practical Myosin II Workflows
2026-08-20
Use (-)-Blebbistatin to reversibly reduce non-muscle myosin II activity in live-cell mechanics, migration, contractility, and developmental assays. This workflow-focused guide connects dose selection and controls with the temperature-sensing findings reported for HCN4, while clearly separating validated evidence from practical assay recommendations.
MK-5108: From Aurora A Biology to Assay Logic
2026-08-19
MK-5108 (VX-689) is a highly selective Aurora A inhibitor for connecting kinase biochemistry with cell-cycle, tumor, and biomarker studies. This article presents an evidence-weighted framework for interpreting Aurora A dependence, selecting assays, and translating results into xenograft research.
Dorsomorphin (Compound C) for Reliable Cell Assays
2026-08-19
A scenario-based guide to using Dorsomorphin (Compound C), SKU B3252, in viability, proliferation, AMPK, autophagy, and BMP-signaling experiments. It connects formulation and storage decisions with data interpretation, controls, and recent evidence on metabolic regulation in osteogenesis.
Anlotinib Hydrochloride: Mechanism & Research
2026-08-18
Anlotinib hydrochloride is a multi-target tyrosine kinase inhibitor with strong anti-angiogenic activity centered on VEGFR2, PDGFRβ, and FGFR1. Preclinical evidence supports its use in endothelial-cell assays and cancer research, while pharmacokinetic and safety findings define important experimental boundaries.
STING agonist-1: STING Pathway Research Guide
2026-08-18
STING agonist-1 is a DMSO-soluble small-molecule agonist for controlled STING signaling research. The compound supports innate-immunity and cancer-immunology workflows, while the cited ESCC study provides mechanistic context rather than direct validation of B7835.
EMD638683: SGK1 Inhibitor Research Guide
2026-08-17
EMD638683 is a selective SGK1 inhibitor that also targets SGK2 and SGK3 and suppresses SGK-dependent NDRG1 phosphorylation. Preclinical evidence connects this mechanism with endothelial stiffness, blood-pressure regulation, radiation-associated cancer-cell responses, and colon-tumor growth, but the compound remains a research tool rather than a clinical treatment.
Targeted SPP1 Inhibition Reprograms Tumor Myeloid Cells
2026-08-16
The reference study developed a phenotypic macrophage screen to identify small molecules that reduce SPP1 expression, then incorporated promising hits into a TAM-avid polymeric nanoconstruct. Its lead formulation, CANDI460, lowered SPP1 in vitro and in vivo and produced tumor remissions in several murine models, providing a preclinical framework for myeloid-cell reprogramming rather than broad macrophage depletion.
Streptavidin – Cy5 for USP42 Apoptosis Assays
2026-08-15
Streptavidin – Cy5 converts biotinylated antibodies, probes, and proteins into a far-red readout suited to USP42, JNK, and p38 apoptosis workflows. This guide explains how to connect mechanistic cancer biology with immunofluorescence, immunohistochemistry, and flow cytometry while controlling background, spectral spillover, and sample-to-sample variability.
CGRP/SP–Piezo2 Signaling in Trigeminal Allodynia
2026-08-15
Liao et al. identify a Ca2+-dependent CGRP/SP–Piezo2 positive-feedback loop that links trigeminal root compression, neuroinflammation, and mechanical allodynia. Their rat and in vitro experiments position ATP, PKC, ERK1/2, and p38 MAPK as signaling components along the trigeminal ganglion–Merkel cell axis, while also highlighting cAMP signaling as a potentially actionable pathway.
Leucovorin Calcium in Gastric Cancer Assembloids
2026-08-14
Leucovorin Calcium can function as more than a methotrexate rescue reagent: it is a mechanistic probe for separating epithelial folate dependence from stromal modulation in patient-derived gastric cancer assembloids. This article translates recent assembloid findings into a rigorous framework for assay design and interpretation.
CD44-Driven Copper Accumulation in Ulcerative Colitis
2026-08-14
A 2026 Cellular Signalling study links CD44 upregulation and impaired ATP7A-mediated copper export to the activation of Ly6Chi macrophages in ulcerative colitis. Its integrated single-cell, proteomic, pharmacological, and cellular evidence positions copper-associated oxidative stress as a mechanistic bridge between macrophage activation and intestinal inflammation, while also defining important requirements for interpreting ROS measurements.
Pemetrexed Workflows for Tumor and Mesothelioma Models
2026-08-13
Build reproducible Pemetrexed assays around folate-pathway inhibition, concentration-response profiling, and DNA-repair-aware combination testing. This workflow distinguishes routine antiproliferative screening from precision experiments in non-small cell lung carcinoma research and malignant mesothelioma models.
Endothelial SGK1 Drives Salt-Induced Vascular Stiffening
2026-08-13
Zhang and colleagues show that endothelial SGK1 is a causal mediator of salt- and mineralocorticoid-associated vascular stiffening, linking sodium-channel regulation to actin remodeling. Genetic deletion and pharmacological inhibition converged on reduced endothelial and aortic stiffness, providing a mechanistic framework for hypertension research.
3-Deazaadenosine hydrochloride in m6A Assays
2026-08-12
3-Deazaadenosine hydrochloride provides a pathway-level way to test how SAHH-dependent methylation influences IGF2BP1–TUBB4B signaling in hepatic stellate cells. This guide explains assay design, controls, interpretation, and the limits of using global methylation perturbation to study m6A biology.
461 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page